EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension

Brenda M Y Leung, Priya Srikanth, Lisa Robinette, Alisha M Bruton, Gabriella Tost, Irene Hatsu, L Eugene Arnold, Jeanette M Johnstone

European Child & Adolescent Psychiatry · 2024

DOI: 10.1007/s00787-023-02236-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Child & Adolescent Psychiatry, 2024. Verfasst von Brenda M Y Leung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Lethbridge, 4401 University Drive, Lethbridge, AB, Canada. brenda.leung@uleth.ca. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Micronutrients. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS, NCATS NIH HHS, Calgary Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youth (MADDY) study evaluated the efficacy and safety of a multinutrient formula for children with ADHD and emotional dysregulation. The post-RCT open-label extension (OLE) compared the effect of treatment duration (8 weeks vs 16 weeks) on ADHD symptoms, height velocity, and adverse events (AEs). METHODS: Children aged 6-12 years randomized to multinutrients vs. placebo for 8 weeks (RCT), received an 8-week OLE for a total of 16 weeks. Assessments included the Clinical Global Impression-Improvement (CGI-I), Child and Adolescent Symptom Inventory-5 (CASI-5), Pediatric Adverse Events Rating Scale (PAERS), and anthropometric measures (height and weight). RESULTS: Of the 126 in the RCT, 103 (81%) continued in the OLE. For those initially assigned to placebo, CGI-I responders increased from 23% in the RCT to 64% in the OLE; those who took multinutrients for 16 weeks increased from 53% (RCT) to 66% responders (OLE). Both groups improved on the CASI-5 composite score and subscales from week 8 to week 16 (all p-values < 0.01). The group taking 16 weeks of multinutrients had marginally greater height growth (2.3 cm) than those with 8 weeks (1.8 cm) (p = 0.07). No difference in AEs between groups was found. CONCLUSION: The response rate to multinutrients by blinded clinician ratings at 8 weeks was maintained to 16 weeks; the response rate in the group initially assigned to placebo improved significantly with 8 weeks of multinutrients and almost caught up with 16 weeks. Longer time on multinutrients did not result in greater AEs, confirming an acceptable safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityMicronutrientsHumansChildMaleFemaleTreatment OutcomeDouble-Blind MethodDietary Supplements

Stichwörter der Autor:innen

ADHDChildrenMultinutrientsOpen-labelRCT

Substanzen

Micronutrients

Autor:innen und Institutionen

  • Faculty of Health Sciences, University of Lethbridge, 4401 University Drive, Lethbridge, AB, Canada. brenda.leung@uleth.ca.
  • Oregon Health & Science University-Portland State University School of Public Health, Portland, OR, USA.
  • Department of Human Sciences, The Ohio State University, Columbus, OH, USA.
  • Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
  • Department of Psychiatry & Behavioral Health, The Ohio State University, Columbus, OH, USA.
  • Helfgott Research Institute, National University of Natural Medicine, Portland, OR, USA.

Förderung

  • NCCIH NIH HHS
  • NCATS NIH HHS
  • Calgary Foundation
  • Foundation for Excellence in Mental Health Care
  • Emmy Droog Chair in Complementary and Alternative Healthcare
  • National Center for Complementary and Integrative Health
  • National Center for Advancing Translational Sciences
  • Gratis Foundation

Zitieren

APA

Leung, B. M. Y., Srikanth, P., Robinette, L., Bruton, A. M., Tost, G., Hatsu, I., Arnold, L. E., & Johnstone, J. M. (2024). Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-023-02236-2

Vancouver

Leung BMY, Srikanth P, Robinette L, Bruton AM, Tost G, Hatsu I, et al. Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension. European Child & Adolescent Psychiatry. 2024. doi:10.1007/s00787-023-02236-2

BibTeX
@article{Leung2024,
  author = {Leung, Brenda M Y and Srikanth, Priya and Robinette, Lisa and Bruton, Alisha M and Tost, Gabriella and Hatsu, Irene and Arnold, L Eugene and Johnstone, Jeanette M},
  title = {Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension},
  journal = {European Child & Adolescent Psychiatry},
  year = {2024},
  doi = {10.1007/s00787-023-02236-2}
}
Kostenlos starten →